Neurology News and Research

Latest Neurology News and Research

FDA approves InSightec's ExAblate Neuro system clinical trial for tremor dominant Parkinson's Disease

InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration to begin a Phase I clinical trial evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor dominant Parkinson's Disease.

20 Aug 2012

NYU Langone's Hospital for Joint Diseases achieves Magnet recognition by ANCC

NYU Langone Medical Center's Hospital for Joint Diseases (HJD) has achieved Magnet recognition by the American Nurses Credentialing Center (ANCC), the international accrediting body that recognizes healthcare organizations focused on nursing excellence.

18 Aug 2012

Damage to the ventromedial prefrontal cortex increases credulity

Everyone knows the adage: "If something sounds too good to be true, then it probably is." Why, then, do some people fall for scams and why are older folks especially prone to being duped? An answer, it seems, is because a specific area of the brain has deteriorated or is damaged, according to researchers at the University of Iowa.

17 Aug 2012

Research examines racial and ethnic differences in strokes

Blacks who survived a stroke caused by bleeding in the brain had higher blood pressure than whites a year later, according to a study published today in the journal Stroke. The finding might help explain why blacks have a greater risk of suffering a second stroke than whites.

17 Aug 2012

Febrile seizures increase hippocampal injury risk

Children with febrile status epilepticus are at risk for hippocampal injury and show abnormalities in the development of this brain area, show findings from a prospective multicenter study.

16 Aug 2012

People with no dementia symptoms and high protein levels more likely to avoid the disease

People who are free of dementia and have high levels of a protein that indicates the presence of inflammation have relatives who are more likely to avoid the disease as well, according to a new study published in the August 15, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Aug 2012

Cedars-Sinai's ICT-107 doubles median survival of patients with malignant brain tumor

An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain tumor, Cedars-Sinai Medical Center researchers reported in Cancer Immunology, Immunotherapy, published online Aug. 3.

16 Aug 2012

Combination of exercise and S-nitrosoglutathione improves recovery from stroke

In a study published in the current issue of Restorative Neurology and Neuroscience scientists report that a therapy combining exercise with the neurovascular protective agent S-nitrosoglutathione (GSNO) improved recovery from stroke in a rat model. GSNO is a compound found naturally in the body and it has no known side effects or toxicity.

16 Aug 2012

Deep brain stimulation has important role in treating severe Tourette’s

Ten out of 11 patients with severe Tourette’s Syndrome have reported improvement after receiving deep brain stimulation surgery, according to University of New South Wales research published in the American Journal of Psychiatry.

15 Aug 2012

Short-term intervention alters neural architecture of stutterers

A short-term intervention in patients who stutter can help reorganize the intrinsic functional architecture of speech–language processes, a Chinese study shows.

15 Aug 2012

Trial to test efficacy of NeuRx Diaphragm Pacing System in people with Lou Gehrig's disease

The Muscular Dystrophy Association (MDA) and The ALS Association today announced a joint commitment to provide funding for a phase 2 clinical trial that will test efficacy of the NeuRx Diaphragm Pacing System (DPS) in people with amyotrophic lateral sclerosis (ALS).

15 Aug 2012

Two papers may help identify gene variants that contribute to OCD or Tourette syndrome

Two papers that will appear in the journal Molecular Psychiatry, both receiving advance online release, may help identify gene variants that contribute to the risks of developing obsessive-compulsive disorder (OCD) or Tourette syndrome (TS). Both multi-institutional studies were led by Massachusetts General Hospital (MGH) investigators, and both are the first genome-wide association studies (GWAS) in the largest groups of individuals affected by the conditions.

15 Aug 2012

Schizophrenia and the immune system: an interview with Prof Cyndi Shannon Weickert

Schizophrenia is the most disabling disease impacting youth today. It impacts 1% of the total population and typically causes withdrawal from society, loss in IQ, disordered thought and speech, hallucinations and delusions.

14 Aug 2012

Latrepiridine reduces level of at least two neurodegeneration-related proteins in mice

14 Aug 2012

Eating egg yolks accelerates atherosclerosis in a manner similar to smoking

Newly published research led by Dr. David Spence of Western University, Canada, shows that eating egg yolks accelerates atherosclerosis in a manner similar to smoking cigarettes.

14 Aug 2012

Researchers discover gene mutations linked to spinocerebellar ataxia

A global hunt for the cause of a crippling inherited nerve disorder has found its target. The discovery opens the door for better diagnosis and treatment of this particular disease - but also for better understanding of why nerves in the brain's movement-controlling center die, and how new DNA-mapping techniques can find the causes of other diseases that run in families.

13 Aug 2012

Latrepirdine demonstrates new potential against neurodegenerative conditions

The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.

13 Aug 2012

Epigenetic factors involved in treatment-resistance to schizophrenia drugs

Researchers at Mount Sinai School of Medicine may have discovered why certain drugs to treat schizophrenia are ineffective in some patients. Published online in Nature Neuroscience, the research will pave the way for a new class of drugs to help treat this devastating mental illness, which impacts one percent of the world's population, 30 percent of whom do not respond to currently available treatments.

13 Aug 2012

Taro, Sun Pharma enter merger agreement

Sun Pharmaceutical Industries Ltd. and Taro Pharmaceutical Industries Ltd. announced today that they have entered into a merger agreement together with certain affiliates of Sun Pharma.

13 Aug 2012

Migraines not associated with cognitive decline

Migraines currently affect about 20 percent of the female population, and while these headaches are common, there are many unanswered questions surrounding this complex disease. Previous studies have linked this disorder to an increased risk of stroke and structural brain lesions, but it has remained unclear whether migraines had other negative consequences such as dementia or cognitive decline.

12 Aug 2012

Neurology News and Research

Latest Neurology News and Research

FDA approves InSightec's ExAblate Neuro system clinical trial for tremor dominant Parkinson's Disease

NYU Langone's Hospital for Joint Diseases achieves Magnet recognition by ANCC

Damage to the ventromedial prefrontal cortex increases credulity

Research examines racial and ethnic differences in strokes

Febrile seizures increase hippocampal injury risk

People with no dementia symptoms and high protein levels more likely to avoid the disease

Cedars-Sinai's ICT-107 doubles median survival of patients with malignant brain tumor

Combination of exercise and S-nitrosoglutathione improves recovery from stroke

Deep brain stimulation has important role in treating severe Tourette’s

Short-term intervention alters neural architecture of stutterers

Trial to test efficacy of NeuRx Diaphragm Pacing System in people with Lou Gehrig's disease

Two papers may help identify gene variants that contribute to OCD or Tourette syndrome

Schizophrenia and the immune system: an interview with Prof Cyndi Shannon Weickert

Latrepiridine reduces level of at least two neurodegeneration-related proteins in mice

Eating egg yolks accelerates atherosclerosis in a manner similar to smoking

Researchers discover gene mutations linked to spinocerebellar ataxia

Latrepirdine demonstrates new potential against neurodegenerative conditions

Epigenetic factors involved in treatment-resistance to schizophrenia drugs

Taro, Sun Pharma enter merger agreement

Migraines not associated with cognitive decline

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Neurology News and Research

Latest Neurology News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in